TransCode Therapeutics stock price
NASDAQ:RNAZ · Nasdaq · Healthcare · sector #16$1.66-1.19%Oct 21 close · provisional
Loading chart…
TransCode Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is RNAZ.
TransCode Therapeutics last closed at $1.66 (-1.19%) on 2026-10-21. Listed on Nasdaq. Trailing 12 months PER is -0.0×. Its overall grade ranks 689 of 726 stocks in Healthcare.
About this company
TransCode Therapeutics last closed at $1.66 (-1.19%) on 2026-10-21. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 689/726
Valuation grade C+
Related stocks
- ModernaCompetitor
- BioNTechCompetitor
- Alnylam PharmaceuticalsCompetitor
About TransCode Therapeutics
- What technical signals does TransCode Therapeutics (RNAZ) have?
- TransCode Therapeutics current technical signals: no active technical signal.
- Is TransCode Therapeutics a cup-and-handle pattern?
- No. TransCode Therapeutics has no valid Cup signal right now.
- What published figures are available for TransCode Therapeutics?
- Market cap: $1.52M. Trailing 12 months PER: -0.0×. Latest quarter PBR: 0.01×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about TransCode Therapeutics, or open the plan table on the main site.
Ask Q about TransCode Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy